Cargando…
Deficient neurotransmitter systems and synaptic function in frontotemporal lobar degeneration—Insights into disease mechanisms and current therapeutic approaches
Frontotemporal lobar degeneration (FTLD) comprises a heterogenous group of fatal neurodegenerative diseases and, to date, no validated diagnostic or prognostic biomarkers or effective disease-modifying therapies exist for the different clinical or genetic subtypes of FTLD. Current treatment strategi...
Autores principales: | Huber, Nadine, Korhonen, Sonja, Hoffmann, Dorit, Leskelä, Stina, Rostalski, Hannah, Remes, Anne M., Honkakoski, Paavo, Solje, Eino, Haapasalo, Annakaisa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9095474/ https://www.ncbi.nlm.nih.gov/pubmed/34799692 http://dx.doi.org/10.1038/s41380-021-01384-8 |
Ejemplares similares
-
FTLD Patient–Derived Fibroblasts Show Defective Mitochondrial Function and Accumulation of p62
por: Leskelä, Stina, et al.
Publicado: (2021) -
Serum neurofilament light chain is a discriminative biomarker between frontotemporal lobar degeneration and primary psychiatric disorders
por: Katisko, Kasper, et al.
Publicado: (2019) -
Patient-derived skin fibroblasts as a model to study frontotemporal lobar degeneration
por: Hoffmann, Dorit, et al.
Publicado: (2022) -
Astrocytes and Microglia as Potential Contributors to the Pathogenesis of C9orf72 Repeat Expansion-Associated FTLD and ALS
por: Rostalski, Hannah, et al.
Publicado: (2019) -
Peripheral inflammatory markers and clinical correlations in patients with frontotemporal lobar degeneration with and without the C9orf72 repeat expansion
por: Katisko, Kasper, et al.
Publicado: (2019)